CDKN2A and astrocytic tumor: The utility of methylthioadenosine phosphorylase (MTAP) IHC as a surrogate marker of CDKN2A HD in astrocytic tumors has been demonstrated [12], as has been that of p16 IHC in a few EPN-ZFTA cases [11].